St. Jude Medical reveals that its neuromodulation division, formerly Advanced Neuromodulation Systems, has adopted the St. Jude Medical name.

The St. Jude Medical Neuromodulation Division unveiled its new brand identity and showcased its flagship products at the 12th annual North American Neuromodulation Society (NANS) meeting in Las Vegas.

St. Jude Medical acquired Advanced Neuromodulation Systems in 2005, and continued to develop, manufacture and market implantable neuromodulation products under that name.

A new corporate brand identity features the theme, "More Control. Less Risk." The message reflects St. Jude Medical's dedication to advancing the practice of medicine by focusing on reducing risk wherever possible and contributing to successful outcomes for every patient.

The company is developing new technologies to address a growing list of neurological disorders. DOTmed News has learned that clinical studies are currently under way for Parkinson's disease, essential tremor, migraine headaches and major depressive disorder among others.

St. Jude Medical is showcasing the world's smallest neurostimulator for chronic pain, the Eon Mini, which was launched in September 2008. It is also showing an expanded portfolio of products including EonC, St. Jude Medical's first extended life nonrechargeable neurostimulator and Cinch anchor, an accessory designed to secure neurostimulation leads to mitigate lead migration.

The company presented 15 poster and oral presentations at the meeting representing research in areas like deep brain stimulation for depression, peripheral field nerve stimulation for chronic pain and spinal cord stimulation for chronic pain of the back, arms and legs. These presentations reflect on the ongoing collaboration with physicians to develop new therapies for patients who have exhausted most other therapeutic options.

More Voices